Design of Topical Ocular Ciprofloxacin Nanoemulsion for the Management of Bacterial Keratitis

Bacterial keratitis (BK) is a critical ocular infection that can lead to serious visual disability. Ciprofloxacin (CIP), moxifloxacin (MOX), and levofloxacin (LFX) have been accepted as monotherapies by the US Food and Drug Administration for BK treatment. CIP is available commercially at 0.3% w/v c...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Ahmed Adel Ali, Cai, Chuntian, Dudhipala, Narendar, Majumdar, Soumyajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998883/
https://www.ncbi.nlm.nih.gov/pubmed/33802394
http://dx.doi.org/10.3390/ph14030210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998883/
https://www.ncbi.nlm.nih.gov/pubmed/33802394
http://dx.doi.org/10.3390/ph14030210

Ejemplares similares